Jane Street
AVXL icon

Jane Street’s Anavex Life Sciences AVXL Stock Holding History

Jane Street’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7K Buy
+10,300
New +$30.5K ﹤0.01% 11132
2026
Q1 		– Sell
-66,500
Closed -$237K – 11550
2025
Q4 		$237K Sell
66,500
-23,300
-26% -$143K ﹤0.01% 9358
2025
Q3 		$799K Buy
89,800
+17,200
+24% +$174K ﹤0.01% 6806
2025
Q2 		$669K Sell
72,600
-19,700
-21% -$168K ﹤0.01% 6391
2025
Q1 		$792K Buy
92,300
+52,900
+134% +$500K ﹤0.01% 6005
2024
Q4 		$423K Buy
+39,400
New +$303K ﹤0.01% 7133
2024
Q2 		– Sell
-14,600
Closed -$74.3K – 9335
2024
Q1 		$74.3K Sell
14,600
-56,800
-80% -$320K ﹤0.01% 8643
2023
Q4 		$665K Sell
71,400
-459,100
-87% -$3.16M ﹤0.01% 6281
2023
Q3 		$3.47M Buy
530,500
+426,100
+408% +$3.39M ﹤0.01% 3149
2023
Q2 		$849K Sell
104,400
-181,500
-63% -$1.56M ﹤0.01% 5485
2023
Q1 		$2.45M Buy
285,900
+95,700
+50% +$955K ﹤0.01% 3472
2022
Q4 		$1.76M Buy
190,200
+41,500
+28% +$443K ﹤0.01% 4045
2022
Q3 		$1.53M Sell
148,700
-62,200
-29% -$656K ﹤0.01% 4642
2022
Q2 		$2.11M Sell
210,900
-26,800
-11% -$254K ﹤0.01% 4066
2022
Q1 		$2.93M Buy
237,700
+33,200
+16% +$408K ﹤0.01% 4013
2021
Q4 		$3.55M Sell
204,500
-4,300
-2% -$81.7K ﹤0.01% 3405
2021
Q3 		$3.75M Sell
208,800
-156,800
-43% -$3.12M ﹤0.01% 3237
2021
Q2 		$8.36M Buy
365,600
+316,800
+649% +$4.69M ﹤0.01% 1928
2021
Q1 		$730K Buy
48,800
+7,900
+19% +$86.3K ﹤0.01% 6077
2020
Q4 		$221K Buy
+40,900
New +$216K ﹤0.01% 6818
2017
Q2 		– Sell
-15,000
Closed -$86K – 4307
2017
Q1 		$86K Buy
+15,000
New +$77.5K ﹤0.01% 3984

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street's AVXL Position: Q2 2026 in Review

Jane Street sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 725,003 shares — an estimated $2.15M sold.

Jane Street first reported a position in AVXL in Q4 2015 and held it in 27 quarters. The position peaked at $4.7M in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Jane Street reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 725,003 Anavex Life Sciences shares in Q2 2026, an estimated $2.15M.
  • Jane Street first reported a position in Anavex Life Sciences in Q4 2015 and held it in 27 quarters.
  • Jane Street's Anavex Life Sciences position peaked at $4.7M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.